BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33601403)

  • 1. [Latin-American experience in cryoablation of paroxysmal and persistent atrial fibrillation using second generation cryo-balloon. Acute success and 12 months of follow-up].
    Scazzuso F; González JL; Rodríguez G; Coria-Sandoval P; Camargo-Ballestas J; Moreno M; Merriam T; Hemingway L; Muratore C
    Arch Cardiol Mex; 2021 Feb; 91(2):208-214. PubMed ID: 33601403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project.
    Perego GB; Iacopino S; Molon G; Arena G; Verlato R; Pieragnoli P; Curnis A; Allocca G; Nicolis D; Sciarra L; Catanzariti D; Senatore G; Rovaris G; Brasca F; Tondo C;
    J Cardiol; 2019 Jul; 74(1):19-26. PubMed ID: 30948185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project.
    Tondo C; Iacopino S; Pieragnoli P; Molon G; Verlato R; Curnis A; Landolina M; Allocca G; Arena G; Fassini G; Sciarra L; Luzi M; Manfrin M; Padeletti L;
    Heart Rhythm; 2018 Mar; 15(3):363-368. PubMed ID: 29107190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
    Packer DL; Kowal RC; Wheelan KR; Irwin JM; Champagne J; Guerra PG; Dubuc M; Reddy V; Nelson L; Holcomb RG; Lehmann JW; Ruskin JN;
    J Am Coll Cardiol; 2013 Apr; 61(16):1713-23. PubMed ID: 23500312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Procedure Outcomes and Quality-of-Life Improvement 12 Months Post-Cryoballoon Ablation in Persistent Atrial Fibrillation: Results From the Multicenter CRYO4PERSISTENT AF Trial.
    Boveda S; Metzner A; Nguyen DQ; Chun KRJ; Goehl K; Noelker G; Deharo JC; Andrikopoulos G; Dahme T; Lellouche N; Defaye P
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1440-1447. PubMed ID: 30466850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study.
    Knight BP; Novak PG; Sangrigoli R; Champagne J; Dubuc M; Adler SW; Svinarich JT; Essebag V; Hokanson R; Kueffer F; Jain SK; John RM; Mansour M;
    JACC Clin Electrophysiol; 2019 Mar; 5(3):306-314. PubMed ID: 30898232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of a single procedure cryoballoon ablation for the treatment of atrial fibrillation: A real-world multicenter experience in Portugal.
    Silva Cunha P; Fonseca P; Laranjo S; Montenegro Sá F; Tereno Valente B; Portugal G; Gonçalves H; Nogueira da Silva M; Brandão L; Martins Oliveira M; Primo J
    Rev Port Cardiol; 2023 Apr; 42(4):363-370. PubMed ID: 36634763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry.
    Chun KRJ; Okumura K; Scazzuso F; Keun On Y; Kueffer FJ; Braegelmann KM; Kaur Khelae S; Al-Kandari F; Földesi C;
    J Arrhythm; 2021 Apr; 37(2):356-367. PubMed ID: 33850577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry.
    Kimura M; Kobori A; Nitta J; Hirao K; Shizuta S; Kurita T; Okishige K; Kumagai K; Koyama J; Hiroshima K; Inaba O; Goya M; Yamauchi Y; Kueffer FJ; Becker D; Okumura K
    J Interv Card Electrophysiol; 2022 Sep; 64(3):695-703. PubMed ID: 35119586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation using the third-generation cryoballoon provides an enhanced ability to assess time to pulmonary vein isolation facilitating the ablation strategy: Short- and long-term results of a multicenter study.
    Aryana A; Kowalski M; O'Neill PG; Koo CH; Lim HW; Khan A; Hokanson RB; Bowers MR; Kenigsberg DN; Ellenbogen KA;
    Heart Rhythm; 2016 Dec; 13(12):2306-2313. PubMed ID: 27503480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term effect of thermal-guided second-generation cryoablation in paroxysmal and persistent atrial fibrillation.
    Dulai R; Uy CP; Kassir Y; Maravilla VA; Patel N; Furniss S; Sulke N; Veasey RA
    Indian Pacing Electrophysiol J; 2021; 21(5):261-266. PubMed ID: 34038768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation.
    Wasmer K; Dechering DG; Köbe J; Mönnig G; Pott C; Frommeyer G; Lange PS; Kochhäuser S; Eckardt L
    Clin Res Cardiol; 2016 Sep; 105(9):738-43. PubMed ID: 27048420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
    Pokushalov E; Romanov A; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):274-9. PubMed ID: 23210695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: Results from the Cryo-DOSING Study (Cryoballoon-ablation DOSING Based on the Assessment of Time-to-Effect and Pulmonary Vein Isolation Guidance).
    Aryana A; Kenigsberg DN; Kowalski M; Koo CH; Lim HW; O'Neill PG; Bowers MR; Hokanson RB; Ellenbogen KA;
    Heart Rhythm; 2017 Sep; 14(9):1319-1325. PubMed ID: 28625929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of cryoballoon ablation for the treatment of atrial fibrillation: First European results from the cryo AF Global Registry.
    Földesi C; Misiková S; Ptaszyński P; Todd D; Herzet JM; Braegelmann KM; Kueffer FJ; Drephal C; Steinwender C; Zucchelli G; Neuzil P; Chun KRJ
    Pacing Clin Electrophysiol; 2021 May; 44(5):883-894. PubMed ID: 33813746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Efficacy of Empiric Thoracic Vein Isolation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation in Patients Without Structural Heart Disease.
    Ejima K; Henmi R; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):266-272. PubMed ID: 28054729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial.
    Su WW; Reddy VY; Bhasin K; Champagne J; Sangrigoli RM; Braegelmann KM; Kueffer FJ; Novak P; Gupta SK; Yamane T; Calkins H;
    Heart Rhythm; 2020 Nov; 17(11):1841-1847. PubMed ID: 32590151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience in a Brazilian Center with Cryoablation for Electric Isolation of the Pulmonary Veins in Paroxysmal and Persistent Atrial Fibrillation - Preliminary Results in Brazil.
    Boghossian SHC; Barbosa EC; Boghossian E; Rangel L; Benchimol-Barbosa PR; Alcantara ML; Fagundes M; Felix A; Mourilhe-Rocha R
    Arq Bras Cardiol; 2020 Sep; 115(3):528-535. PubMed ID: 32696858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation.
    Liu J; Xia Y; Zhang H; Li X; Zhang S; Fang P
    Herz; 2021 Apr; 46(Suppl 1):82-88. PubMed ID: 32002565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.